These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Assessment of background levels of autoantibodies as a prognostic marker for severe SARS-CoV-2 infection. Sullivan FM; Tello A; Rauchhaus P; Santiago VH; Daly F J Circ Biomark; 2022; 11():24-27. PubMed ID: 35517714 [TBL] [Abstract][Full Text] [Related]
44. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine. Kanduc D; Shoenfeld Y Immunol Res; 2020 Oct; 68(5):310-313. PubMed ID: 32946016 [No Abstract] [Full Text] [Related]
45. Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19. Marino Gammazza A; Légaré S; Lo Bosco G; Fucarino A; Angileri F; Conway de Macario E; Macario AJ; Cappello F Cell Stress Chaperones; 2020 Sep; 25(5):737-741. PubMed ID: 32754823 [TBL] [Abstract][Full Text] [Related]
46. SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Lucchese G; Flöel A Cell Stress Chaperones; 2020 Sep; 25(5):731-735. PubMed ID: 32729001 [TBL] [Abstract][Full Text] [Related]
47. Immunoserologic Detection and Diagnostic Relevance of Cross-Reactive Autoantibodies in Coronavirus Disease 2019 Patients. Schiaffino MT; Di Natale M; García-Martínez E; Navarro J; Muñoz-Blanco JL; Demelo-Rodríguez P; Sánchez-Mateos P J Infect Dis; 2020 Oct; 222(9):1439-1443. PubMed ID: 32738141 [TBL] [Abstract][Full Text] [Related]
48. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Dotan A; Muller S; Kanduc D; David P; Halpert G; Shoenfeld Y Autoimmun Rev; 2021 Apr; 20(4):102792. PubMed ID: 33610751 [TBL] [Abstract][Full Text] [Related]
49. SARS-CoV-2 infection as a trigger of autoimmune response. Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235 [TBL] [Abstract][Full Text] [Related]
50. COVID-19 and autoimmune diseases. Liu Y; Sawalha AH; Lu Q Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890 [TBL] [Abstract][Full Text] [Related]
51. IgM autoantibodies recognizing ACE2 are associated with severe COVID-19. Casciola-Rosen L; Thiemann DR; Andrade F; Trejo Zambrano MI; Hooper JE; Leonard EK; Spangler JB; Cox AL; Machamer CE; Sauer L; Laeyendecker O; Garibaldi BT; Ray SC; Mecoli CA; Christopher-Stine L; Gutierrez-Alamillo L; Yang Q; Hines D; Clarke WA; Rothman R; Pekosz A; Fenstermacher KJ; Wang Z; Zeger SL; Rosen A medRxiv; 2020 Oct; ():. PubMed ID: 33083808 [TBL] [Abstract][Full Text] [Related]
52. COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful? Pascolini S; Vannini A; Deleonardi G; Ciordinik M; Sensoli A; Carletti I; Veronesi L; Ricci C; Pronesti A; Mazzanti L; Grondona A; Silvestri T; Zanuso S; Mazzolini M; Lalanne C; Quarneti C; Fusconi M; Giostra F; Granito A; Muratori L; Lenzi M; Muratori P Clin Transl Sci; 2021 Mar; 14(2):502-508. PubMed ID: 32989903 [TBL] [Abstract][Full Text] [Related]